# A Study of Tislelizumab in Combination With Investigational Agents in Participants With Non-Small Cell Lung Cancer

Source: https://onco.cc/trials/nct05635708/  
OnCo record `nct05635708` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 2 trial of Tislelizumab, Carboplatin, Cisplatin in non-small-cell lung cancer and small-cell lung cancer, run by BeiGene, active and no longer recruiting.

## Summary

A Study of Tislelizumab in Combination With Investigational Agents in Participants With Non-Small Cell Lung Cancer is a phase 2 interventional study registered as NCT05635708 by BeiGene, with 400 participants planned, started 2023-03-07 and due to reach its primary completion in 2025-12-31. Interventions recorded: Tislelizumab, BGB-A445, LBL-007, Carboplatin, Cisplatin. Conditions listed: Non-small Cell Lung Cancer, Metastatic Non-small Cell Lung Cancer. No results are recorded here; the registry entry is the source.

## Fields

- Kind: Trial
- Status: active
- Last checked: 2026-09-16
- Tags: ctgov-ingest
- Registry id: NCT05635708
- Phase: 2
- Setting: Master Protocol: A Phase 2, Open-label, Multi-arm Study of Tislelizumab in Combination With Investigational Agents With or Without Chemotherapy in Patients With Previously Untreated, Locally Advanced, Unresectable, or Metastatic Non-Small Cell Lung Cancer
- Sponsor: BeiGene
- Enrolled: 400

## Sources

- ClinicalTrials.gov NCT05635708: https://clinicaltrials.gov/study/NCT05635708

## Connected records

- cancers: [Non-small-cell lung cancer](https://onco.cc/cancers/nsclc/), [Small-cell lung cancer](https://onco.cc/cancers/sclc/)
- drugs: [Carboplatin](https://onco.cc/drugs/carboplatin/), [Cisplatin](https://onco.cc/drugs/cisplatin/), [Paclitaxel / nab-paclitaxel](https://onco.cc/drugs/paclitaxel/), [Pemetrexed](https://onco.cc/drugs/pemetrexed/), [Tislelizumab](https://onco.cc/drugs/tislelizumab/)
- companies: [BeOne Medicines (formerly BeiGene)](https://onco.cc/companies/beone/)

---
JSON: https://onco.cc/api/v1/entities/nct05635708.json